Hylton Kalvaria

Hylton Kalvaria is an experienced executive in the life sciences sector, currently serving as Chief Commercial Officer at Helix since August 2023 and as an Advisor at Rock Health Capital since March 2023. Kalvaria has advised various healthcare companies since July 2022, focusing on commercial strategy and product development within real world data and evidence generation. Previously, as President and Chief Commercial Officer at Mendel.ai, Kalvaria contributed to a groundbreaking platform for analyzing healthcare records. Kalvaria held significant roles at Verana Health as Chief Business Officer and SVP of Commercial and Strategic Partnerships, and at Flatiron Health as Head of West Coast Life Sciences. Earlier positions include strategic roles at Genentech and ZS Associates. Kalvaria holds an MBA from Duke University’s Fuqua School of Business and a BS in Economics from Duke University.